Click for best price
NSAIDs Market Size, Share 2022
Market Analysis and Insights: Global NSAIDs Market
The global NSAIDs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NSAIDs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NSAIDs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NSAIDs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NSAIDs market.
Global NSAIDs Scope and Market Size
NSAIDs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global NSAIDs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the NSAIDs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Segment by Application
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes NSAIDs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of NSAIDs, with price, sales, revenue, and global market share of NSAIDs from 2019 to 2022.
Chapter 3, the NSAIDs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NSAIDs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the NSAIDs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of NSAIDs.
Chapter 13, 14, and 15, to describe NSAIDs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 NSAIDs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States NSAIDs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 NSAIDs Product Introduction
1.2 Global NSAIDs Outlook 2017 VS 2022 VS 2028
1.2.1 Global NSAIDs Sales in US$ Million for the Year 2017-2028
1.2.2 Global NSAIDs Sales in Volume for the Year 2017-2028
1.3 United States NSAIDs Outlook 2017 VS 2022 VS 2028
1.3.1 United States NSAIDs Sales in US$ Million for the Year 2017-2028
1.3.2 United States NSAIDs Sales in Volume for the Year 2017-2028
1.4 NSAIDs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States NSAIDs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of NSAIDs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 NSAIDs Market Dynamics
1.5.1 NSAIDs Industry Trends
1.5.2 NSAIDs Market Drivers
1.5.3 NSAIDs Market Challenges
1.5.4 NSAIDs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 NSAIDs Market Segment by Type
2.1.1 Aspirin
2.1.2 Ibuprofen
2.1.3 Naproxen
2.1.4 Nabumetone
2.1.5 Others
2.2 Global NSAIDs Market Size by Type
2.2.1 Global NSAIDs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global NSAIDs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global NSAIDs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States NSAIDs Market Size by Type
2.3.1 United States NSAIDs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States NSAIDs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States NSAIDs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 NSAIDs Market Segment by Application
3.1.1 Back Pain Treatment
3.1.2 Osteoarthritis Treatment
3.1.3 Other Disease Treatment
3.2 Global NSAIDs Market Size by Application
3.2.1 Global NSAIDs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global NSAIDs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global NSAIDs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States NSAIDs Market Size by Application
3.3.1 United States NSAIDs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States NSAIDs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States NSAIDs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global NSAIDs Competitor Landscape by Company
4.1 Global NSAIDs Market Size by Company
4.1.1 Top Global NSAIDs Manufacturers Ranked by Revenue (2021)
4.1.2 Global NSAIDs Revenue by Manufacturer (2017-2022)
4.1.3 Global NSAIDs Sales by Manufacturer (2017-2022)
4.1.4 Global NSAIDs Price by Manufacturer (2017-2022)
4.2 Global NSAIDs Concentration Ratio (CR)
4.2.1 NSAIDs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of NSAIDs in 2021
4.2.3 Global NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global NSAIDs Manufacturing Base Distribution, Product Type
4.3.1 Global NSAIDs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers NSAIDs Product Type
4.3.3 Date of International Manufacturers Enter into NSAIDs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States NSAIDs Market Size by Company
4.5.1 Top NSAIDs Players in United States, Ranked by Revenue (2021)
4.5.2 United States NSAIDs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States NSAIDs Sales by Players (2020, 2021 & 2022)
5 Global NSAIDs Market Size by Region
5.1 Global NSAIDs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global NSAIDs Market Size in Volume by Region (2017-2028)
5.2.1 Global NSAIDs Sales in Volume by Region: 2017-2022
5.2.2 Global NSAIDs Sales in Volume Forecast by Region (2023-2028)
5.3 Global NSAIDs Market Size in Value by Region (2017-2028)
5.3.1 Global NSAIDs Sales in Value by Region: 2017-2022
5.3.2 Global NSAIDs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America NSAIDs Market Size YoY Growth 2017-2028
6.1.2 North America NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific NSAIDs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific NSAIDs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe NSAIDs Market Size YoY Growth 2017-2028
6.3.2 Europe NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America NSAIDs Market Size YoY Growth 2017-2028
6.4.2 Latin America NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa NSAIDs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bayer
7.1.1 Bayer Corporation Information
7.1.2 Bayer Description and Business Overview
7.1.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Bayer NSAIDs Products Offered
7.1.5 Bayer Recent Development
7.2 Novacap
7.2.1 Novacap Corporation Information
7.2.2 Novacap Description and Business Overview
7.2.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Novacap NSAIDs Products Offered
7.2.5 Novacap Recent Development
7.3 Abbott
7.3.1 Abbott Corporation Information
7.3.2 Abbott Description and Business Overview
7.3.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Abbott NSAIDs Products Offered
7.3.5 Abbott Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer NSAIDs Products Offered
7.4.5 Pfizer Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporation Information
7.5.2 Johnson & Johnson Description and Business Overview
7.5.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Johnson & Johnson NSAIDs Products Offered
7.5.5 Johnson & Johnson Recent Development
7.6 Cigna
7.6.1 Cigna Corporation Information
7.6.2 Cigna Description and Business Overview
7.6.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Cigna NSAIDs Products Offered
7.6.5 Cigna Recent Development
7.7 Geri-Care Pharmaceuticals
7.7.1 Geri-Care Pharmaceuticals Corporation Information
7.7.2 Geri-Care Pharmaceuticals Description and Business Overview
7.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Geri-Care Pharmaceuticals NSAIDs Products Offered
7.7.5 Geri-Care Pharmaceuticals Recent Development
7.8 Perrigo Company
7.8.1 Perrigo Company Corporation Information
7.8.2 Perrigo Company Description and Business Overview
7.8.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Perrigo Company NSAIDs Products Offered
7.8.5 Perrigo Company Recent Development
7.9 Kopran
7.9.1 Kopran Corporation Information
7.9.2 Kopran Description and Business Overview
7.9.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Kopran NSAIDs Products Offered
7.9.5 Kopran Recent Development
7.10 Merck Sharp & Dohme
7.10.1 Merck Sharp & Dohme Corporation Information
7.10.2 Merck Sharp & Dohme Description and Business Overview
7.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Merck Sharp & Dohme NSAIDs Products Offered
7.10.5 Merck Sharp & Dohme Recent Development
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Corporation Information
7.11.2 Sun Pharmaceutical Industries Description and Business Overview
7.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Sun Pharmaceutical Industries NSAIDs Products Offered
7.11.5 Sun Pharmaceutical Industries Recent Development
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Corporation Information
7.12.2 GlaxoSmithKline Description and Business Overview
7.12.3 GlaxoSmithKline NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 GlaxoSmithKline Products Offered
7.12.5 GlaxoSmithKline Recent Development
7.13 Reddy Pharmaceuticals
7.13.1 Reddy Pharmaceuticals Corporation Information
7.13.2 Reddy Pharmaceuticals Description and Business Overview
7.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Reddy Pharmaceuticals Products Offered
7.13.5 Reddy Pharmaceuticals Recent Development
7.14 Verywell
7.14.1 Verywell Corporation Information
7.14.2 Verywell Description and Business Overview
7.14.3 Verywell NSAIDs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Verywell Products Offered
7.14.5 Verywell Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 NSAIDs Industry Chain Analysis
8.2 NSAIDs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 NSAIDs Distributors
8.3 NSAIDs Production Mode & Process
8.4 NSAIDs Sales and Marketing
8.4.1 NSAIDs Sales Channels
8.4.2 NSAIDs Distributors
8.5 NSAIDs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. NSAIDs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. NSAIDs Market Trends
Table 3. NSAIDs Market Drivers
Table 4. NSAIDs Market Challenges
Table 5. NSAIDs Market Restraints
Table 6. Global NSAIDs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States NSAIDs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global NSAIDs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States NSAIDs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top NSAIDs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global NSAIDs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global NSAIDs Revenue Share by Manufacturer, 2017-2022
Table 13. Global NSAIDs Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global NSAIDs Sales Share by Manufacturer, 2017-2022
Table 15. Global NSAIDs Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global NSAIDs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs as of 2021)
Table 18. Top Players of NSAIDs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers NSAIDs Product Type
Table 20. Date of International Manufacturers Enter into NSAIDs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top NSAIDs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States NSAIDs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States NSAIDs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States NSAIDs Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States NSAIDs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global NSAIDs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global NSAIDs Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global NSAIDs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global NSAIDs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global NSAIDs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America NSAIDs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America NSAIDs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific NSAIDs Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific NSAIDs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe NSAIDs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe NSAIDs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America NSAIDs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa NSAIDs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa NSAIDs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa NSAIDs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Bayer Corporation Information
Table 43. Bayer Description and Business Overview
Table 44. Bayer NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Bayer NSAIDs Product
Table 46. Bayer Recent Development
Table 47. Novacap Corporation Information
Table 48. Novacap Description and Business Overview
Table 49. Novacap NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Novacap Product
Table 51. Novacap Recent Development
Table 52. Abbott Corporation Information
Table 53. Abbott Description and Business Overview
Table 54. Abbott NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Abbott Product
Table 56. Abbott Recent Development
Table 57. Pfizer Corporation Information
Table 58. Pfizer Description and Business Overview
Table 59. Pfizer NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Pfizer Product
Table 61. Pfizer Recent Development
Table 62. Johnson & Johnson Corporation Information
Table 63. Johnson & Johnson Description and Business Overview
Table 64. Johnson & Johnson NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Johnson & Johnson Product
Table 66. Johnson & Johnson Recent Development
Table 67. Cigna Corporation Information
Table 68. Cigna Description and Business Overview
Table 69. Cigna NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Cigna Product
Table 71. Cigna Recent Development
Table 72. Geri-Care Pharmaceuticals Corporation Information
Table 73. Geri-Care Pharmaceuticals Description and Business Overview
Table 74. Geri-Care Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Geri-Care Pharmaceuticals Product
Table 76. Geri-Care Pharmaceuticals Recent Development
Table 77. Perrigo Company Corporation Information
Table 78. Perrigo Company Description and Business Overview
Table 79. Perrigo Company NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Perrigo Company Product
Table 81. Perrigo Company Recent Development
Table 82. Kopran Corporation Information
Table 83. Kopran Description and Business Overview
Table 84. Kopran NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Kopran Product
Table 86. Kopran Recent Development
Table 87. Merck Sharp & Dohme Corporation Information
Table 88. Merck Sharp & Dohme Description and Business Overview
Table 89. Merck Sharp & Dohme NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Merck Sharp & Dohme Product
Table 91. Merck Sharp & Dohme Recent Development
Table 92. Sun Pharmaceutical Industries Corporation Information
Table 93. Sun Pharmaceutical Industries Description and Business Overview
Table 94. Sun Pharmaceutical Industries NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Sun Pharmaceutical Industries Product
Table 96. Sun Pharmaceutical Industries Recent Development
Table 97. GlaxoSmithKline Corporation Information
Table 98. GlaxoSmithKline Description and Business Overview
Table 99. GlaxoSmithKline NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. GlaxoSmithKline Product
Table 101. GlaxoSmithKline Recent Development
Table 102. Reddy Pharmaceuticals Corporation Information
Table 103. Reddy Pharmaceuticals Description and Business Overview
Table 104. Reddy Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Reddy Pharmaceuticals Product
Table 106. Reddy Pharmaceuticals Recent Development
Table 107. Verywell Corporation Information
Table 108. Verywell Description and Business Overview
Table 109. Verywell NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Verywell Product
Table 111. Verywell Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. NSAIDs Customers List
Table 115. NSAIDs Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. NSAIDs Product Picture
Figure 2. Global NSAIDs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global NSAIDs Market Size 2017-2028 (US$ Million)
Figure 4. Global NSAIDs Sales 2017-2028 (K Pcs)
Figure 5. United States NSAIDs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States NSAIDs Market Size 2017-2028 (US$ Million)
Figure 7. United States NSAIDs Sales 2017-2028 (K Pcs)
Figure 8. United States NSAIDs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States NSAIDs Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. NSAIDs Report Years Considered
Figure 11. Product Picture of Aspirin
Figure 12. Product Picture of Ibuprofen
Figure 13. Product Picture of Naproxen
Figure 14. Product Picture of Nabumetone
Figure 15. Product Picture of Others
Figure 16. Global NSAIDs Market Share by Type in 2022 & 2028
Figure 17. Global NSAIDs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global NSAIDs Sales Market Share in Value by Type (2017-2028)
Figure 19. Global NSAIDs Sales by Type (2017-2028) & (K Pcs)
Figure 20. Global NSAIDs Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global NSAIDs Price by Type (2017-2028) & (USD/Pcs)
Figure 22. United States NSAIDs Market Share by Type in 2022 & 2028
Figure 23. United States NSAIDs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States NSAIDs Sales Market Share in Value by Type (2017-2028)
Figure 25. United States NSAIDs Sales by Type (2017-2028) & (K Pcs)
Figure 26. United States NSAIDs Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States NSAIDs Price by Type (2017-2028) & (USD/Pcs)
Figure 28. Product Picture of Back Pain Treatment
Figure 29. Product Picture of Osteoarthritis Treatment
Figure 30. Product Picture of Other Disease Treatment
Figure 31. Global NSAIDs Market Share by Application in 2022 & 2028
Figure 32. Global NSAIDs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 33. Global NSAIDs Sales Market Share in Value by Application (2017-2028)
Figure 34. Global NSAIDs Sales by Application (2017-2028) & (K Pcs)
Figure 35. Global NSAIDs Sales Market Share in Volume by Application (2017-2028)
Figure 36. Global NSAIDs Price by Application (2017-2028) & (USD/Pcs)
Figure 37. United States NSAIDs Market Share by Application in 2022 & 2028
Figure 38. United States NSAIDs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. United States NSAIDs Sales Market Share in Value by Application (2017-2028)
Figure 40. United States NSAIDs Sales by Application (2017-2028) & (K Pcs)
Figure 41. United States NSAIDs Sales Market Share in Volume by Application (2017-2028)
Figure 42. United States NSAIDs Price by Application (2017-2028) & (USD/Pcs)
Figure 43. North America NSAIDs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 44. North America NSAIDs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. U.S. NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Canada NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe NSAIDs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 48. Europe NSAIDs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. U.K. NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific NSAIDs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 55. Asia-Pacific NSAIDs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Taiwan NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Indonesia NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Thailand NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Malaysia NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Philippines NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America NSAIDs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 67. Latin America NSAIDs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Middle East & Africa NSAIDs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 72. Middle East & Africa NSAIDs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 73. Turkey NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. U.A.E NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. NSAIDs Value Chain
Figure 77. NSAIDs Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
